Investigational Drug Information for Basmisanil
✉ Email this page to a colleague
What is the drug development status for Basmisanil?
Basmisanil is an investigational drug.
There have been 4 clinical trials for Basmisanil.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 30th 2022.
The most common disease conditions in clinical trials are Ischemic Stroke, Down Syndrome, and Syndrome. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
There are ten US patents protecting this investigational drug and one hundred and thirty-three international patents.
Summary for Basmisanil
| US Patents | 10 |
| International Patents | 133 |
| US Patent Applications | 30 |
| WIPO Patent Applications | 12 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2022-03-30) |
| Vendors | 42 |
Recent Clinical Trials for Basmisanil
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children With Dup15q Syndrome | Hoffmann-La Roche | Phase 2 |
| A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke | Hoffmann-La Roche | Phase 2 |
| A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics | Hoffmann-La Roche | Phase 2 |
Clinical Trial Summary for Basmisanil
Top disease conditions for Basmisanil
Top clinical trial sponsors for Basmisanil
US Patents for Basmisanil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Basmisanil | ⤷ Subscribe | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Subscribe |
| Basmisanil | ⤷ Subscribe | Isoxazolo-pyridine derivatives | Hoffmann-La Roche Inc (Nutley, NJ) | ⤷ Subscribe |
| Basmisanil | ⤷ Subscribe | Process for the preparation of isoxazolyl-methoxy nicotinic acids | Hoffman-La Roche Inc. (Nutley, NJ) | ⤷ Subscribe |
| Basmisanil | ⤷ Subscribe | Solid forms | Hoffmann-La Roche Inc. (Nutley, NJ) | ⤷ Subscribe |
| Basmisanil | ⤷ Subscribe | Use of selective GABA A .alpha.5 negative allosteric modulators for the treatment of central nervous system conditions | Hoffmann-La Roche Inc. (Nutley, NJ) | ⤷ Subscribe |
| Basmisanil | ⤷ Subscribe | Isoxazolo-pyridine derivatives | Roche Palo Alto LLC (So. San Francisco, CA) | ⤷ Subscribe |
| Basmisanil | ⤷ Subscribe | Isoxazolo-pyridine derivatives | Roche Palo Alto LLC (So. San Francisco, CA) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Basmisanil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Basmisanil | Australia | AU2017261372 | 2036-05-05 | ⤷ Subscribe |
| Basmisanil | Canada | CA3023278 | 2036-05-05 | ⤷ Subscribe |
| Basmisanil | China | CN107847398 | 2036-05-05 | ⤷ Subscribe |
| Basmisanil | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Subscribe |
| Basmisanil | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Subscribe |
| Basmisanil | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Subscribe |
| Basmisanil | Japan | JP2019520866 | 2036-05-05 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
